Chesterfield, VA, United States of America

Mark Mabry

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Wyeth. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Mabry. Retrieved from https://idiyas.com/inventor/mark-mabry

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Mabry: Innovator in Pharmaceutical Composition

Introduction

Mark Mabry is a notable inventor based in Chesterfield, VA (US). He has made significant contributions to the field of pharmaceuticals, particularly with his innovative approach to chewable tablet formulations.

Latest Patents

Mark Mabry holds a patent for a chewable tablet containing phenylephrine. This chewable pharmaceutical composition comprises phenylephrine, an artificial sweetener, and a substantially aldehyde-free matrix. The composition is designed to maintain phenylephrine stability suitable for a typical commercial product with a two-year shelf life. Additionally, the patent includes a method of manufacture for the composition and a method of use.

Career Highlights

Mark Mabry is associated with Wyeth, a prominent company in the pharmaceutical industry. His work focuses on developing formulations that enhance the stability and usability of pharmaceutical products.

Collaborations

Mark has collaborated with notable coworkers, including Josephine Fubara and Aaron Lewis Durr, contributing to the advancement of pharmaceutical innovations.

Conclusion

Mark Mabry's contributions to the field of pharmaceuticals, particularly through his patent for a chewable tablet containing phenylephrine, highlight his innovative spirit and dedication to improving medication accessibility. His work continues to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…